
  
    
      
        Background_NNP
        Nerve_NNP growth_NN factor_NN (_( NGF_NNP )_) ,_, a_DT prototypical_JJ neurotrophic_JJ
        factor_NN and_CC a_DT member_NN of_IN the_DT neurotrophin_NN family_NN ,_, promotes_VBZ a_DT
        wide_JJ range_NN of_IN responses_NNS in_IN its_PRP$ target_NN cells_NNS ._. These_DT range_NN
        from_IN neuronal_NN differentiation_NN ,_, maintenance_NN of_IN survival_NN ,_, and_CC
        regulation_NN of_IN metabolic_JJ activities_NNS [_NN for_IN review_NN see_VB [_NN 1_CD 2_CD 3_CD
        ]_NN ._. Many_JJ of_IN these_DT actions_NNS include_VBP and_CC require_VB
        transcriptional_NN regulation_NN [_NN 4_CD 5_CD ]_NN ._. However_RB ,_, the_DT greater_JJR
        part_NN of_IN the_DT changes_NNS in_IN gene_NN expression_NN that_WDT underlie_VB the_DT
        NGF_NNP response_NN remain_VB to_TO be_VB elucidated_JJ ._. The_DT PC_NN 12_CD line_NN of_IN rat_NN
        pheochromocytoma_NN cells_NNS [_NN 6_CD ]_NN has_VBZ proved_VBN to_TO be_VB a_DT
        particularly_RB favorable_JJ system_NN for_IN detecting_VBG NGF-responsive_NNP
        changes_NNS in_IN gene_NN expression_NN [_NN 7_CD 8_CD 9_CD 10_CD 11_CD ]_NN ._. These_DT cells_NNS
        resemble_VBP sympathico-pheochromo-blasts_JJ and_CC upon_IN exposure_NN to_TO
        NGF_NNP cease_VB proliferation_NN and_CC acquire_VB ,_, in_IN a_DT transcription_NN
        dependent_JJ mechanism_NN ,_, many_JJ of_IN the_DT properties_NNS of_IN post-mitotic_JJ
        sympathetic_JJ neurons_NNS including_VBG neurite_NN outgrowth_NN and_CC
        electrical_JJ excitability_NN ._. The_DT robust_JJ nature_NN of_IN the_DT response_NN
        of_IN PC_NN 12_CD cells_NNS to_TO NGF_NNP coupled_VBN with_IN their_PRP$ capacity_NN to_TO be_VB
        examined_VBN both_DT before_IN and_CC at_IN various_JJ times_NNS after_IN exposure_NN to_TO
        the_DT factor_NN has_VBZ greatly_RB facilitated_JJ study_NN of_IN the_DT NGF_NNP
        mechanism_NN of_IN action_NN ,_, including_VBG gene_NN regulation_NN [_NN 12_CD ]_NN ._.
        To_TO obtain_VB a_DT comprehensive_JJ and_CC quantitative_JJ over-view_JJ of_IN
        NGF-promoted_NNP gene_NN regulation_NN ,_, we_PRP [_NN 11_CD ]_NN have_VBP used_VBN SAGE_NNP
        (_( Serial_JJ Analysis_NNP of_IN Gene_NNP Expression_NNP )_) ._. In_IN this_DT technique_NN [_NN
        13_CD 14_CD 15_CD ]_NN cellular_JJ transcripts_NNS are_VBP converted_VBN to_TO SAGE_NNP
        "_'' tags_NNS "_'' which_WDT are_VBP sequenced_JJ ,_, quantified_VBN and_CC ,_, in_IN many_JJ cases_NNS ,_,
        matched_VBN with_IN known_VBN genes_NNS ._. By_IN comparing_VBG SAGE_NNP profiles_NNS for_IN
        cells_NNS in_IN different_JJ states_NNS (_( as_IN for_IN example_NN before_IN and_CC after_IN
        exposure_NN to_TO NGF_NNP )_) ,_, it_PRP is_VBZ thus_RB possible_JJ to_TO obtain_VB a_DT
        comprehensive_JJ view_NN of_IN gene_NN expression_NN and_CC regulation_NN ._.
        Moreover_RB ,_, if_IN a_DT sufficient_JJ number_NN of_IN SAGE_NNP tags_NNS are_VBP analyzed_VBN ,_,
        changes_NNS in_IN expression_NN levels_NNS of_IN individual_JJ transcripts_NNS can_MD
        be_VB associated_VBN with_IN a_DT high_JJ level_NN of_IN statistical_JJ significance_NN
        [_NN 13_CD ]_NN ._.
        Initial_JJ analysis_NN of_IN approximately_RB 157_CD ,_, 000_CD SAGE_NNP tags_NNS from_IN
        PC_NN 12_CD cells_NNS cultured_JJ without_IN or_CC with_IN NGF_NNP for_IN 9_CD days_NNS revealed_VBD
        nearly_RB 800_CD transcripts_NNS (_( of_IN a_DT total_NN of_IN at_IN least_JJS 21_CD ,_, 000_CD )_) that_WDT
        are_VBP regulated_VBN by_IN ±_NN 6_CD -_: fold_VB or_CC greater_JJR in_IN response_NN to_TO NGF_NNP [_NN
        11_CD ]_NN ._. Of_IN these_DT ,_, approximately_RB 150_CD were_VBD assignable_JJ to_TO named_VBN
        genes_NNS of_IN known_VBN functions_NNS that_WDT regulate_VB cellular_JJ behaviors_NNS
        ranging_VBG from_IN actin_NN and_CC microtubule_NN cytoskeleton_NN
        assembly_NN /_NN disassembly_RB ,_, gene_NN transcription_NN ,_, RNA_NNP processing_NN ,_,
        neurotransmission_NN ,_, and_CC energetics_NNS ._. A_DT variety_NN of_IN criteria_NNS
        supported_VBD the_DT reliability_NN of_IN the_DT quantitative_JJ findings_NNS
        revealed_VBN by_IN our_PRP$ SAGE_NNP analysis_NN [_NN 11_CD ]_NN ._.
        In_IN the_DT present_JJ study_NN ,_, we_PRP have_VBP extended_VBN our_PRP$ SAGE_NNP
        profiling_VBG of_IN naïve_NN and_CC long-term_JJ NGF-treated_NNP PC_NNP 12_CD cells_NNS to_TO
        over_IN 163_CD ,_, 000_CD tags_NNS representing_VBG over_IN 22_CD ,_, 000_CD unique_JJ
        transcripts_NNS ._. Analysis_NNP of_IN these_DT reveals_VBZ the_DT presence_NN of_IN
        transcripts_NNS encoding_VBG 74_CD different_JJ ribosomal_JJ proteins_NNS (_( RPs_NNP )_) ._.
        Surprisingly_RB ,_, we_PRP find_VBP that_IN long-term_JJ NGF_NNP exposure_NN leads_VBZ to_TO
        statistically_RB significant_JJ changes_NNS in_IN relative_JJ abundance_NN of_IN
        at_IN least_JJS half_NN of_IN these_DT transcripts_NNS by_IN factors_NNS of_IN up_IN to_TO
        nearly_RB 5_CD -_: fold_VB ._. In_IN addition_NN ,_, a_DT time_NN course_NN for_IN one_CD of_IN the_DT RP_NNP
        transcripts_NNS (_( encoding_VBG RP_NNP L_NNP 9_CD )_) reveals_VBZ that_IN its_PRP$ relative_JJ
        abundance_NN begins_VBZ to_TO change_VB within_IN 1_CD hr_NN and_CC is_VBZ maximally_RB
        regulated_VBN by_IN 8_CD hr_NN of_IN NGF_NNP exposure_NN ._.
      
      
        Results_NNS
        
          SAGE_NNP libraries_NNS
          SAGE_NNP libraries_NNS were_VBD generated_VBN and_CC analyzed_VBN as_RB
          previously_RB described_VBD [_NN 11_CD ]_NN from_IN matched_VBN sets_NNS of_IN PC_NN 12_CD
          cells_NNS before_IN and_CC after_IN 9_CD days_NNS of_IN exposure_NN to_TO NGF_NNP ._. The_DT
          present_JJ analysis_NN is_VBZ based_VBN on_IN 76_CD ,_, 280_CD 15_CD -_: mer_NN tags_NNS from_IN
          NGF-untreated_NNP PC_NNP 12_CD cells_NNS and_CC 87_CD ,_, 004_CD tags_NNS from_IN NGF-treated_NNP
          cells_NNS (_( after_IN exclusion_NN of_IN duplicate_VB ditags_NNS ,_, mitochondrial_NN
          transcripts_NNS and_CC repetitive_JJ elements_NNS )_) ._. Consideration_NNP of_IN
          tags_NNS observed_VBD twice_RB or_CC more_JJR between_IN the_DT two_CD libraries_NNS
          indicated_VBD the_DT presence_NN of_IN approximately_RB 22_CD ,_, 000_CD unique_JJ
          transcripts_NNS ._. Of_IN these_DT ,_, approximately_RB 10_CD %_NN were_VBD regulated_VBN
          by_IN more_JJR than_IN 3_CD -_: fold_VB in_IN response_NN to_TO NGF_NNP and_CC approximately_RB
          4_CD %_NN by_IN 6_CD -_: fold_VB or_CC more_JJR ._.
        
        
          Detection_NNP and_CC quantification_NN of_IN transcripts_NNS
          encoding_VBG ribosomal_JJ proteins_NNS
          Transcripts_NNP represented_VBN by_IN SAGE_NNP tags_NNS were_VBD identified_VBN
          by_IN direct_JJ matches_NNS of_IN tags_NNS with_IN the_DT appropriate_JJ sequences_NNS
          of_IN known_VBN rat_NN genes_NNS (_( present_JJ in_IN GenBank_NNP )_) or_CC through_IN
          matches_NNS of_IN tags_NNS with_IN appropriate_JJ sequences_NNS of_IN rat_NN ESTs_NNP
          (_( present_JJ in_IN NCBI_NNP Unigene_NNP )_) that_WDT were_VBD in_IN turn_NN found_VBD to_TO
          overlap_VB with_IN known_VBN rat_NN genes_NNS ._. Positive_JJ identification_NN
          required_VBN that_IN the_DT transcript_NN or_CC EST_NNP have_VBP a_DT poly_RB
          adenylation_NN signal_NN and_CC poly_RB A_DT tail_NN ,_, and_CC that_IN the_DT tag_NN
          followed_VBD the_DT most_JJS 3_CD '_POS CATG_NNP of_IN the_DT transcript_NN ._. In_IN this_DT way_NN
          74_CD tags_NNS were_VBD unambiguously_RB assignable_JJ to_TO known_VBN rat_NN
          transcripts_NNS encoding_VBG proteins_NNS described_VBD as_IN ribosomal_JJ
          components_NNS ._. Available_NNP sequences_NNS encoding_VBG rat_NN ribosomal_JJ
          proteins_NNS L_NNP 15_CD and_CC S_NNP 8_CD do_VBP not_RB contain_VB a_DT CATG_NNP sequence_NN and_CC
          hence_RB SAGE_NNP tags_NNS for_IN these_DT could_MD not_RB be_VB identified_VBN ._. In_IN
          addition_NN ,_, rat_NN sequence_NN data_NNS for_IN transcripts_NNS encoding_VBG RPs_NNP
          L_NNP 2_CD ,_, L_NNP 25_CD ,_, L_NNP 33_CD and_CC S_NNP 1_CD are_VBP not_RB presently_RB available_JJ in_IN
          GenBank_NNP or_CC Unigene_NNP ._.
          Table_NNP 1_CD lists_NNS the_DT tags_NNS in_IN our_PRP$ libraries_NNS corresponding_JJ
          to_TO transcripts_NNS for_IN ribosomal_JJ proteins_NNS along_IN with_IN their_PRP$
          relative_JJ abundances_NNS ._. Considering_VBG that_IN the_DT eukaryotic_JJ
          ribosome_NN contains_VBZ approximately_RB 82_CD proteins_NNS ,_, our_PRP$ analysis_NN
          includes_VBZ transcripts_NNS encoding_VBG a_DT major_JJ proportion_NN of_IN the_DT
          known_VBN ribosomal_JJ proteins_NNS ._.
        
        
          Relative_NNP expression_NN of_IN transcripts_NNS for_IN ribosomal_JJ
          proteins_NNS
          Among_IN the_DT information_NN provided_VBN by_IN analysis_NN of_IN SAGE_NNP
          data_NNS is_VBZ the_DT relative_JJ abundances_NNS of_IN transcripts_NNS ._. The_DT data_NNS
          given_VBN in_IN Table_NNP 1_CD and_CC Figure_NN 1_CD show_NN the_DT relative_JJ abundances_NNS
          of_IN transcripts_NNS for_IN PC_NN 12_CD cell_NN ribosomal_JJ proteins_NNS with_IN
          respect_NN to_TO one_CD another_DT as_RB well_RB as_IN with_IN respect_NN to_TO the_DT
          total_JJ cell_NN complement_VB of_IN transcripts_NNS ._. As_IN noted_VBD above_IN ,_, our_PRP$
          analysis_NN has_VBZ detected_VBN at_IN least_JJS 22_CD ,_, 000_CD unique_JJ transcripts_NNS
          in_IN PC_NN 12_CD cells_NNS ._. The_DT 74_CD ribosomal_JJ protein_NN transcripts_NNS
          identified_VBN here_RB thus_RB account_VB for_IN no_RB more_JJR than_IN 0_CD ._. 33_CD %_NN of_IN
          this_DT total_NN ._. By_IN contrast_NN ,_, for_IN NGF-untreated_NNP and_CC -_: treated_VBN
          PC_NN 12_CD cells_NNS ,_, tags_NNS corresponding_JJ to_TO the_DT 74_CD identified_VBN RP_NNP
          transcripts_NNS represent_VBP 5_CD ._. 2_CD %_NN and_CC 3_CD ._. 5_CD %_NN ,_, respectively_RB ,_, of_IN
          total_JJ tags_NNS analyzed_VBD ._. As_IN anticipated_VBN ,_, this_DT clearly_RB places_VBZ
          transcripts_NNS for_IN ribosomal_JJ proteins_NNS as_IN a_DT whole_NN in_IN the_DT high_JJ
          abundance_NN category_NN ._.
          The_DT most_RBS abundantly_RB expressed_VBD ribosomal_JJ transcripts_NNS in_IN
          NGF-untreated_NNP PC_NNP 12_CD cells_NNS included_VBD those_DT encoding_VBG
          ribosomal_JJ proteins_NNS S_NNP 15_CD ,_, S_NNP 24_CD and_CC L_NNP 41_CD ._. These_DT each_DT accounted_VBD
          for_IN approximately_RB 0_CD ._. 2_CD -_: 0_CD ._. 35_CD %_NN of_IN total_JJ cell_NN transcripts_NNS ._.
          The_DT high_JJ relative_JJ abundance_NN of_IN these_DT ribosomal_JJ
          transcripts_NNS in_IN NGF-untreated_NNP cells_NNS can_MD be_VB appreciated_VBN by_IN
          the_DT observation_NN that_IN of_IN the_DT 4_CD tags_NNS encountered_VBD more_JJR than_IN
          200_CD times_NNS in_IN our_PRP$ analysis_NN ,_, 2_CD (_( S_NNP 15_CD and_CC S_NNP 24_CD )_) encoded_JJ
          ribosomal_JJ proteins_NNS ;_: moreover_RB ,_, RP_NNP transcripts_NNS represented_VBD
          6_CD of_IN the_DT 13_CD tags_NNS encountered_VBD from_IN 100_CD -_: 200_CD times_NNS and_CC 23_CD of_IN
          the_DT 36_CD tags_NNS encountered_VBD from_IN 50_CD -_: 100_CD times_NNS ._.
          The_DT data_NNS in_IN Table_NNP 1_CD and_CC Figure_NN 1_CD show_NN that_IN NGF_NNP treatment_NN
          resulted_VBD in_IN an_DT overall_JJ decrease_NN in_IN relative_JJ abundance_NN of_IN
          transcripts_NNS encoding_VBG RPs_NNP (_( from_IN 5_CD ._. 2_CD %_NN to_TO 3_CD ._. 5_CD %_NN of_IN total_JJ )_) ._.
          This_DT may_MD reflect_VB in_IN part_NN our_PRP$ observation_NN that_IN NGF_NNP
          treatment_NN increases_VBZ the_DT numbers_NNS of_IN transcripts_NNS
          representing_VBG low-abundance_JJ genes_NNS [_NN 11_CD ]_NN ._. Nevertheless_RB ,_,
          transcripts_NNS for_IN ribosomal_JJ proteins_NNS remained_VBD among_IN the_DT
          most_RBS highly_RB expressed_VBD in_IN the_DT NGF-treated_NNP cells_NNS ._. For_IN
          instance_NN ,_, tags_NNS for_IN RPs_NNP L_NNP 13_CD A_DT ,_, L_NNP 31_CD ,_, L_NNP 37_CD A_DT ,_, S_NNP 24_CD and_CC S_NNP 29_CD had_VBD
          relative_JJ abundances_NNS of_IN 0_CD ._. 1_CD %_NN or_CC more_JJR ._. Of_IN the_DT 56_CD most_RBS
          abundantly_RB expressed_VBD tags_NNS in_IN NGF-treated_NNP cells_NNS ,_, 21_CD
          represent_VB ribosomal_JJ transcripts_NNS ._.
        
        
          NGF_NNP selectively_RB regulates_VBZ the_DT expression_NN of_IN
          transcripts_NNS encoding_VBG ribosomal_JJ proteins_NNS
          In_IN addition_NN to_TO yielding_VBG an_DT overall_JJ decrease_NN in_IN the_DT
          abundance_NN of_IN RP_NNP transcripts_NNS relative_JJ to_TO total_VB cellular_JJ
          transcripts_NNS ,_, long-term_JJ NGF_NNP treatment_NN also_RB promoted_VBD
          selective_JJ changes_NNS in_IN relative_JJ expression_NN of_IN transcripts_NNS
          encoding_VBG individual_JJ RPs_NNP (_( Table_NNP 1_CD ,_, Figs_NNP ._. 2_LS ,_, 3_LS )_) ._.
          Monte-_NNP Carlo_NNP simulation_NN analysis_NN of_IN the_DT SAGE_NNP data_NN
          indicated_VBD that_IN nearly_RB half_NN (_( a_DT total_NN of_IN 35_CD )_) of_IN the_DT 74_CD RP_NNP
          transcripts_NNS underwent_VBD changes_NNS that_WDT were_VBD significant_JJ at_IN
          the_DT 
          P_NN ≤_NN 0_CD ._. 01_CD level_NN (_( see_VB Table_NNP 1_LS )_) ._. Of_IN
          these_DT 35_CD transcripts_NNS ,_, 2_CD /_NN 3_CD were_VBD down-regulated_JJ in_IN response_NN
          to_TO NGF_NNP ._.
          Figure_NN 2_CD shows_VBZ the_DT distribution_NN of_IN fold-changes_JJ in_IN
          transcript_NN levels_NNS in_IN response_NN to_TO NGF_NNP ._. 47_CD of_IN the_DT 74_CD RP_NNP
          transcripts_NNS were_VBD either_CC invariant_NN or_CC showed_VBD changes_NNS of_IN
          2_CD -_: fold_VB or_CC less_JJR ;_: 10_CD individual_JJ transcripts_NNS decreased_VBN by_IN
          3_CD -_: 5_CD fold_VB (_( L_NNP 12_CD ,_, L_NNP 18_CD ,_, L_NNP 24_CD ,_, L_NNP 28_CD ,_, L_NNP 30_CD ,_, S_NNP 15_CD ,_, S_NNP 16_CD ,_, S_NNP 18_CD ,_, S_NNP 19_CD and_CC
          S_NNP 24_CD )_) and_CC one_CD was_VBD elevated_VBD by_IN more_JJR than_IN 3_CD -_: fold_VB (_( L_NNP 17_CD )_) ._.
          In_IN a_DT past_JJ study_NN [_NN 11_CD ]_NN ,_, the_DT differences_NNS in_IN
          NGF-promoted_NNP gene_NN expression_NN revealed_VBN by_IN SAGE_NNP analysis_NN of_IN
          our_PRP$ libraries_NNS were_VBD found_VBN to_TO be_VB highly_RB reliable_JJ based_VBN on_IN
          1_LS )_) the_DT absence_NN of_IN regulation_NN shown_VBN by_IN a_DT number_NN of_IN
          anticipated_VBN "_'' housekeeping_NN "_'' genes_NNS including_VBG β-actin_JJ ,_, 2_LS )_)
          the_DT observation_NN that_IN the_DT vast_JJ majority_NN of_IN transcripts_NNS
          were_VBD not_RB responsive_JJ to_TO NGF_NNP ,_, 3_LS )_) the_DT detection_NN of_IN
          anticipated_VBN changes_NNS in_IN expression_NN of_IN a_DT number_NN transcripts_NNS
          previously_RB reported_VBD to_TO be_VB NGF_NNP responsive_JJ ,_, and_CC 4_LS )_) the_DT
          agreement_NN in_IN relative_JJ expression_NN of_IN 20_CD genes_NNS as_IN revealed_VBN
          by_IN SAGE_NNP and_CC northern_JJ blot_NN analyses_NNS ._. To_TO further_VB confirm_VB
          the_DT reliability_NN of_IN our_PRP$ SAGE_NNP findings_NNS ,_, we_PRP used_VBD real_JJ time_NN
          quantitative_JJ PCR_NNP to_TO compare_VB levels_NNS of_IN 5_CD different_JJ RP_NNP
          transcripts_NNS in_IN PC_NN 12_CD cells_NNS treated_VBN with_IN or_CC without_IN NGF_NNP for_IN
          9_CD -_: 12_CD days_NNS ._. As_IN shown_VBN in_IN Figure_NN 4_CD ,_, both_DT techniques_NNS revealed_VBD
          similar_JJ changes_NNS in_IN expression_NN ._.
        
        
          Rapid_JJ regulation_NN of_IN an_DT RP_NNP transcript_NN by_IN NGF_NNP
          We_PRP next_RB determined_VBD the_DT time_NN course_NN with_IN which_WDT NGF_NNP
          regulates_VBZ an_DT RP_NNP transcript_NN ._. For_IN this_DT purpose_NN ,_, we_PRP studied_VBD
          RP_NNP L_NNP 9_CD which_WDT undergoes_NNS a_DT 2_CD ._. 7_CD -_: fold_VB elevation_NN in_IN response_NN to_TO
          long-term_JJ NGF_NNP treatment_NN ._. Because_IN the_DT changes_NNS in_IN
          expression_NN are_VBP relatively_RB small_JJ ,_, we_PRP used_VBD real_JJ time_NN PCR_NNP
          for_IN this_DT end_NN ._. As_IN shown_VBN in_IN Figure_NN 5_CD A_DT ,_, the_DT relative_JJ
          abundance_NN of_IN transcripts_NNS encoding_VBG RP_NNP L_NNP 9_CD were_VBD
          significantly_RB upregulated_JJ by_IN 1_CD hr_NN of_IN NGF_NNP treatment_NN (_( 1_CD ._. 8_CD ±_NN
          0_CD ._. 2_CD -_: fold_VB ,_, n_NN =_SYM 14_CD )_) whereas_IN there_EX was_VBD no_DT significant_JJ change_NN
          in_IN transcripts_NNS encoding_VBG RP_NNP S_NNP 29_CD ,_, which_WDT does_VBZ not_RB undergo_VB
          long-term_JJ NGF_NNP regulation_NN ._. A_DT time_NN course_NN (_( Figure_NN 5_CD B_NNP )_)
          revealed_VBD that_DT elevation_NN of_IN L_NNP 9_CD transcripts_NNS reaches_VBZ maximal_NN
          levels_NNS within_IN 8_CD hrs_NNS of_IN NGF_NNP exposure_NN ._.
        
      
      
        Discussion_NNP
        
          NGF_NNP regulates_VBZ expression_NN of_IN RP_NNP transcripts_NNS
          In_IN the_DT present_JJ work_NN ,_, we_PRP used_VBD SAGE_NNP profiling_VBG to_TO
          identify_VB and_CC quantify_VB the_DT relative_JJ numbers_NNS of_IN transcripts_NNS
          for_IN 74_CD ribosomal_JJ proteins_NNS in_IN rat_NN PC_NN 12_CD cells_NNS before_IN and_CC
          after_IN long-term_JJ exposure_NN to_TO NGF_NNP ._. This_DT has_VBZ permitted_VBN us_PRP to_TO
          detect_VB selective_JJ changes_NNS in_IN transcripts_NNS encoding_VBG specific_JJ
          RPs_NNP ._.
          A_DT number_NN of_IN criteria_NNS support_VBP the_DT reliability_NN of_IN our_PRP$
          findings_NNS ._. The_DT first_JJ regards_VBZ the_DT assignment_NN of_IN SAGE_NNP tags_NNS
          to_TO specific_JJ RP_NNP transcripts_NNS ._. We_PRP required_VBD that_IN all_DT matching_VBG
          ESTs_NNP or_CC transcripts_NNS have_VBP clearly_RB definable_JJ poly_RB A_DT tails_NNS
          and_CC poly_RB adenylation_NN signals_NNS ._. Due_JJ to_TO the_DT extensive_JJ data_NN
          base_VBP for_IN rat_NN RP_NNP transcripts_NNS ,_, it_PRP was_VBD possible_JJ to_TO make_VB all_DT
          matches_VBZ with_IN rat_NN sequences_NNS ._. In_IN addition_NN ,_, we_PRP used_VBD 15_CD mer_NN
          (_( CATG_NNP +_NN 11_CD )_) base_NN SAGE_NNP tags_NNS for_IN our_PRP$ analysis_NN ;_: we_PRP have_VBP
          reported_VBN [_NN 11_CD ]_NN that_IN this_DT leads_VBZ to_TO a_DT significantly_RB more_RBR
          reliable_JJ matching_NN of_IN SAGE_NNP tags_NNS to_TO genes_NNS than_IN with_IN the_DT
          often-used_JJ 14_CD -_: mer_NN tags_NNS ._. A_DT second_JJ indicator_NN of_IN reliability_NN
          stems_VBZ from_IN prior_JJ analysis_NN of_IN our_PRP$ SAGE_NNP libraries_NNS and_CC data_NNS
          obtained_VBN from_IN them_PRP [_NN 11_CD ]_NN ._. For_IN instance_NN ,_, we_PRP have_VBP shown_VBN
          that_IN our_PRP$ SAGE_NNP libraries_NNS show_VBP little_JJ or_CC no_DT NGF-promoted_NNP
          changes_NNS in_IN tag_NN numbers_NNS for_IN transcripts_NNS encoding_VBG a_DT number_NN
          of_IN housekeeping_NN proteins_NNS ._. Moreover_RB ,_, a_DT number_NN of_IN
          transcripts_NNS previously_RB found_VBN by_IN alternative_JJ technologies_NNS
          to_TO respond_VB to_TO NGF_NNP treatment_NN ,_, showed_VBD similar_JJ changes_NNS in_IN
          our_PRP$ SAGE_NNP profiling_VBG study_NN ._. Finally_RB ,_, Northern_NNP blot_NN analysis_NN
          verified_VBN SAGE-predicted_NNP responses_NNS of_IN over_IN 20_CD transcripts_NNS
          to_TO NGF_NNP treatment_NN ._. A_DT third_JJ criterion_NN for_IN reliability_NN was_VBD
          that_IN Monte_NNP Carlo_NNP simulation_NN indicated_VBD that_IN many_JJ of_IN the_DT
          NGF-promoted_NNP responses_NNS of_IN RP_NNP transcripts_NNS were_VBD at_IN a_DT
          probability_NN of_IN 
          P_NN <_NN 0_CD ._. 01_CD ._. Because_IN of_IN the_DT
          relatively_RB high_JJ abundance_NN of_IN many_JJ RP_NNP transcripts_NNS ,_, even_RB
          comparably_RB small_JJ changes_NNS in_IN expression_NN could_MD be_VB detected_VBN
          at_IN this_DT level_NN of_IN significance_NN ._. A_DT last_JJ criterion_NN was_VBD that_IN
          we_PRP used_VBD real_JJ time_NN RT-PCR_NNP to_TO verify_VB effects_NNS of_IN NGF_NNP on_IN five_CD
          RP_NNP transcripts_NNS ._.
          A_DT previous_JJ study_NN by_IN Lee_NNP et_CC al_NN ._. [_NN 8_CD ]_NN ,_, based_VBN on_IN
          comparison_NN of_IN a_DT total_NN of_IN approximately_RB 7_CD ,_, 000_CD random_JJ ESTs_NNP
          from_IN naïve_NN and_CC NGF-treated_NNP PC_NNP 12_CD cells_NNS ,_, reported_VBD an_DT
          NGF-promoted_NNP increase_NN in_IN expression_NN of_IN RPL_NNP 7_CD transcripts_NNS
          and_CC a_DT decrease_NN in_IN RPL_NNP 19_CD transcripts_NNS ._. This_DT contrasts_VBZ with_IN
          the_DT current_JJ data_NN which_WDT revealed_VBD no_DT significant_JJ change_NN in_IN
          expression_NN of_IN either_DT of_IN these_DT transcripts_NNS ._. The_DT reason_NN for_IN
          this_DT discrepancy_NN is_VBZ unclear_JJ ,_, but_CC could_MD in_IN part_VB originate_VB
          from_IN the_DT relatively_RB small_JJ number_NN of_IN transcripts_NNS that_WDT were_VBD
          surveyed_VBN in_IN the_DT former_JJ study_NN ._. To_TO our_PRP$ knowledge_NN ,_, there_EX are_VBP
          currently_RB no_DT other_JJ reports_NNS regarding_VBG effects_NNS of_IN NGF_NNP on_IN
          levels_NNS of_IN ribosomal_JJ transcripts_NNS ._.
        
        
          Relative_NNP levels_NNS of_IN RP_NNP transcripts_NNS
          Our_PRP$ observations_NNS indicate_VBP that_IN there_EX is_VBZ a_DT wide_JJ range_NN
          in_IN the_DT numbers_NNS transcripts_NNS per_IN cell_NN that_DT encode_NN
          individual_JJ RPs_NNP ._. For_IN instance_NN ,_, both_DT before_IN and_CC after_IN NGF_NNP
          treatment_NN ,_, there_RB was_VBD over_IN a_DT 10_CD -_: fold_VB difference_NN in_IN the_DT
          relative_JJ numbers_NNS of_IN transcripts_NNS for_IN RPs_NNP L_NNP 7_CD ,_, L_NNP 22_CD ,_, S_NNP 21_CD as_IN
          compared_VBN to_TO those_DT encoding_VBG RP_NNP S_NNP 29_CD ._. Because_IN of_IN the_DT general_JJ
          scarcity_NN of_IN antisera_NN prepared_VBN against_IN mammalian_JJ RPs_NNP ,_, we_PRP
          do_VBP not_RB know_VB whether_IN this_DT is_VBZ reflected_VBN at_IN the_DT protein_NN
          level_NN ._. However_RB ,_, for_IN a_DT number_NN of_IN other_JJ NGF-regulated_NNP
          transcripts_NNS in_IN PC_NN 12_CD cells_NNS ,_, there_EX is_VBZ a_DT good_JJ correlation_NN
          between_IN relative_JJ levels_NNS of_IN message_NN and_CC protein_NN [_NN 11_CD 16_CD 17_CD
          ]_NN ._. Thus_RB ,_, it_PRP may_MD be_VB that_IN although_IN levels_NNS of_IN individual_JJ
          RPs_NNP are_VBP assumed_VBN to_TO be_VB similar_JJ to_TO one_CD another_DT ,_, some_DT may_MD be_VB
          present_JJ in_IN limiting_VBG numbers_NNS ._. Alternatively_RB ,_, there_EX may_MD be_VB
          a_DT considerable_JJ disparity_NN between_IN relative_JJ abundances_NNS of_IN
          RP_NNP transcripts_NNS and_CC their_PRP$ corresponding_JJ proteins_NNS
          A_DT recent_JJ SAGE_NNP study_NN of_IN targets_NNS for_IN N-_NNP myc_NN in_IN a_DT human_JJ
          neuroblastoma_NN cell_NN line_NN [_NN 18_CD ]_NN ,_, reported_VBD relative_JJ
          abundances_NNS for_IN 66_CD RP_NNP transcripts_NNS ._. The_DT existence_NN of_IN such_JJ
          data_NNS permit_VBP us_PRP to_TO compare_VB the_DT relative_JJ levels_NNS of_IN RP_NNP
          transcripts_NNS in_IN two_CD cell_NN types_NNS (_( neuroblastoma_NN and_CC
          pheochromocytoma_NN )_) of_IN related_VBN origin_NN (_( i_NNP ._. e_SYM ._. ,_,
          neural-crest-derived_JJ )_) that_IN both_DT have_VBP the_DT potential_NN for_IN
          neuronal_NN differentiation_NN ._. The_DT 74_CD RP_NNP transcripts_NNS detected_VBD
          here_RB represented_VBN 5_CD ._. 2_CD %_NN of_IN the_DT total_JJ transcripts_NNS in_IN
          NGF-untreated_NNP PC_NNP 12_CD cells_NNS and_CC 3_CD ._. 5_CD %_NN after_IN NGF_NNP treatment_NN ._. By_IN
          contrast_NN ,_, the_DT 66_CD RPs_NNP reported_VBD in_IN the_DT neuroblastoma_NN study_NN
          accounted_VBD for_IN 4_CD ._. 1_CD %_NN of_IN total_JJ transcripts_NNS for_IN cells_NNS without_IN
          N-_NNP myc_NN over-expression_JJ and_CC 12_CD ._. 6_CD %_NN for_IN such_JJ cells_NNS
          transfected_JJ with_IN N-_NNP myc_NN ._. Thus_RB ,_, for_IN non-_NN N-_NNP myc_NN transfected_JJ
          neuroblastoma_NN cells_NNS and_CC PC_NN 12_CD cells_NNS (_( ±_NN NGF_NNP )_) the_DT
          contribution_NN of_IN total_JJ RP_NNP transcripts_NNS lies_VBZ in_IN a_DT similar_JJ
          range_NN and_CC this_DT parameter_NN is_VBZ greatly_RB elevated_VBD in_IN
          neuroblastoma_NN cells_NNS by_IN N-_NNP myc_NN over-expression_JJ ._. With_IN
          respect_NN to_TO transcripts_NNS for_IN individual_JJ RP_NNP 's_POS ,_, there_EX are_VBP
          many_JJ similarities_NNS as_RB well_RB as_IN several_JJ striking_JJ differences_NNS
          between_IN the_DT two_CD cell_NN types_NNS ._. When_WRB NGF-untreated_NNP PC_NNP 12_CD cells_NNS
          are_VBP compared_VBN with_IN non-transfected_JJ neuroblastoma_NN cells_NNS ,_, of_IN
          the_DT 55_CD RP_NNP transcripts_NNS detected_VBD in_IN common_JJ for_IN both_DT
          systems_NNS ,_, about_IN half_NN (_( a_DT total_NN of_IN 28_CD )_) have_VBP relative_JJ
          abundances_NNS within_IN a_DT factor_NN of_IN 2_CD ._. Twenty_CD transcripts_NNS are_VBP
          more_JJR than_IN 3_CD -_: fold_VB higher_JJR in_IN relative_JJ abundance_NN in_IN PC_NN 12_CD
          cells_NNS ._. In_IN two_CD of_IN these_DT cases_NNS (_( S_NNP 9_CD and_CC S_NNP 17_CD )_) no_DT tags_NNS were_VBD
          detected_VBN in_IN the_DT non-transformed_JJ neuroblastoma_NN cells_NNS ;_: in_IN
          several_JJ other_JJ cases_NNS (_( S_NNP 12_CD ,_, S_NNP 24_CD ,_, L_NNP 24_CD )_) the_DT relative_JJ
          abundance_NN in_IN PC_NN 12_CD cells_NNS was_VBD over_IN 20_CD -_: fold_VB that_IN in_IN the_DT
          neuroblastoma_NN cells_NNS ._. For_IN most_JJS of_IN these_DT ,_, expression_NN of_IN
          N-_NNP myc_NN elevated_VBD the_DT neuroblastoma_NN levels_NNS to_TO relative_JJ
          abundances_NNS within_IN 2_CD -_: fold_VB of_IN those_DT in_IN PC_NN 12_CD cells_NNS ._. However_RB ,_,
          for_IN L_NNP 24_CD and_CC S_NNP 24_CD ,_, the_DT relative_JJ abundance_NN in_IN
          N-_NNP myc-expressing_JJ neuroblastoma_NN cells_NNS was_VBD still_RB 1_CD /_NN 3_CD that_IN
          in_IN PC_NN 12_CD cells_NNS ._. Finally_RB 7_CD RP_NNP transcripts_NNS (_( L_NNP 7_CD ,_, L_NNP 11_CD ,_, L_NNP 21_CD ,_,
          L_NNP 30_CD ,_, S_NNP 7_CD ,_, S_NNP 8_CD and_CC P_NN 2_LS )_) were_VBD of_IN 3_CD -_: 5_CD times_NNS lower_JJR abundance_NN in_IN
          PC_NN 12_CD cells_NNS than_IN in_IN neuroblastoma_NN cells_NNS and_CC this_DT
          difference_NN was_VBD appreciably_RB enhanced_VBN when_WRB the_DT NB_NNP cells_NNS
          were_VBD transfected_JJ with_IN N-_NNP myc_NN ._.
          We_PRP have_VBP also_RB compared_VBN our_PRP$ RP_NNP results_NNS with_IN those_DT for_IN
          SAGE_NNP carried_VBD out_IN with_IN pooled_VBN human_JJ adult_NN brain_NN (_( tissue_NN
          supplied_VBN by_IN Gregory_NNP J_NNP ._. Riggins_NNP :_:
          http_NN :_: /_NN /_NN www_NN ._. ncbi_NN ._. nlm_NN ._. nih_NN ._. gov_NN /_NN sage_NN /_NN sagerec_NN ._. cgi_NN ?_. rec_NN =_SYM 161_CD )_) ._.
          Comparison_NNP with_IN data_NNS for_IN NGF-treated_NNP cells_NNS reveals_VBZ
          similarity_NN in_IN relative_JJ abundance_NN within_IN a_DT factor_NN of_IN 2_CD for_IN
          39_CD of_IN the_DT 57_CD RP_NNP transcripts_NNS in_IN common_JJ between_IN the_DT
          libraries_NNS and_CC 48_CD of_IN 57_CD to_TO within_IN a_DT factor_NN of_IN 3_CD ._. However_RB ,_,
          several_JJ large_JJ differences_NNS do_VBP occur_VB ._. For_IN example_NN the_DT
          relative_JJ abundances_NNS of_IN transcripts_NNS encoding_VBG RPs_NNP L_NNP 9_CD ,_, L_NNP 39_CD ,_,
          S_NNP 24_CD ,_, S_NNP 13_CD ,_, and_CC S_NNP 17_CD are_VBP 5_CD -_: 10_CD -_: fold_VB higher_JJR in_IN NGF-treated_NNP
          PC_NNP 12_CD cells_NNS than_IN in_IN the_DT pooled_VBN brain_NN library_NN and_CC
          transcripts_NNS for_IN RP_NNP L_NNP 28_CD are_VBP 8_CD -_: fold_VB lower_JJR ._. These_DT
          observations_NNS reinforce_VBP the_DT notion_NN that_DT expression_NN of_IN
          individual_JJ RP_NNP transcripts_NNS can_MD be_VB significantly_RB variable_JJ
          from_IN cell_NN type_NN to_TO cell_NN type_NN as_RB well_RB as_IN sensitive_JJ to_TO
          extrinsic_JJ signals_NNS ._.
        
        
          Potential_JJ significance_NN of_IN RP_NNP transcript_NN
          regulation_NN
          Although_IN the_DT ribosome_NN has_VBZ been_VBN considered_VBN as_RB a_DT
          "_'' molecular_JJ machine_NN "_'' [_NN 19_CD ]_NN ,_, it_PRP is_VBZ of_IN interest_NN that_IN the_DT
          transcripts_NNS encoding_VBG individual_JJ proteins_NNS of_IN this_DT
          organelle_NN are_VBP subject_JJ to_TO regulation_NN by_IN NGF_NNP ._. Two_CD related_VBN
          questions_NNS emerge_VBP regarding_VBG these_DT findings_NNS :_: how_WRB do_VBP these_DT
          changes_NNS compare_VBP with_IN previous_JJ reports_NNS for_IN regulation_NN of_IN
          RP_NNP transcripts_NNS and_CC what_WP might_MD be_VB the_DT functional_JJ
          consequences_NNS of_IN these_DT changes_NNS ?_.
          A_DT number_NN of_IN studies_NNS have_VBP employed_VBN a_DT variety_NN of_IN
          techniques_NNS to_TO detect_VB changes_NNS in_IN gene_NN expression_NN
          associated_VBN with_IN the_DT oncogenic_JJ state_NN and_CC have_VBP reported_VBN
          selective_JJ elevation_NN of_IN specific_JJ RP_NNP transcripts_NNS in_IN tumors_NNS ._.
          Examples_NNS include_VBP RPs_NNP L_NNP 7_CD a_DT ,_, L_NNP 37_CD and_CC S_NNP 14_CD in_IN prostate_NN tumors_NNS
          and_CC cell_NN lines_NNS [_NN 20_CD ]_NN ;_: RPs_NNP L_NNP 5_CD ,_, L_NNP 7_CD A_DT ,_, L_NNP 18_CD ,_, S_NNP 3_CD ,_, S_NNP 6_CD ,_, S_NNP 8_CD ,_,
          S_NNP 12_CD ,_, S_NNP 13_CD ,_, S_NNP 28_CD ,_, P_NN 0_CD and_CC P_NN 1_CD in_IN colorectal_NN cancers_NNS and_CC cell_NN
          lines_NNS [_NN 21_CD 22_CD 23_CD 24_CD 25_CD 26_CD ]_NN ;_: L_NNP 5_CD in_IN astrocytomas_NNS [_NN 27_CD ]_NN ;_:
          L_NNP 18_CD a_DT in_IN squamous_JJ cell_NN carcinoma_NN [_NN 28_CD ]_NN ;_: L_NNP 19_CD in_IN breast_NN
          tumors_NNS that_IN over-express_JJ erbB-_NN 2_CD [_NN 29_CD ]_NN ;_: RPs_NNP S_NNP 3_CD A_DT ,_, S_NNP 4_CD ,_, and_CC
          S_NNP 17_CD in_IN lymphoid_NN malignancies_NNS [_NN 30_CD ]_NN ;_: L_NNP 38_CD ,_, S_NNP 4_CD ,_, P_NN 0_CD ,_, and_CC P_NN 1_CD
          in_IN rhabdomyosarcoma_NN cell_NN lines_NNS [_NN 31_CD ]_NN ;_: and_CC P_NN 0_CD ,_, P_NN 1_CD ,_, P_NN 2_CD ,_,
          L_NNP 5_CD ,_, L_NNP 9_CD ,_, L_NNP 35_CD ,_, L_NNP 39_CD ,_, S_NNP 3_CD A_DT ,_, S_NNP 10_CD ,_, and_CC S_NNP 17_CD in_IN liver_NN tumors_NNS [_NN 32_CD
          ]_NN ._. In_IN addition_NN ,_, as_IN noted_VBN above_IN ,_, a_DT recent_JJ SAGE_NNP study_NN
          identified_VBD targets_NNS of_IN N-_NNP myc_NN in_IN a_DT human_JJ neuroblastoma_NN cell_NN
          line_NN [_NN 18_CD ]_NN ._. Of_IN 114_CD up-regulated_JJ genes_NNS detected_VBD ,_, 66_CD
          encoded_JJ RPs_NNP with_IN elevations_NNS ranging_VBG from_IN 40_CD %_NN to_TO 37_CD -_: fold_VB ._.
          Several_JJ of_IN these_DT genes_NNS were_VBD also_RB up-regulated_JJ by_IN c-myc_JJ ._.
          Taken_VBN together_RB ,_, these_DT findings_NNS indicate_VBP that_IN the_DT
          transition_NN to_TO the_DT transformed_VBN state_NN is_VBZ associated_VBN with_IN
          elevation_NN of_IN various_JJ RP_NNP transcripts_NNS ._. A_DT potential_JJ
          interpretation_NN of_IN such_JJ observations_NNS is_VBZ that_IN this_DT
          up-regulation_JJ reflects_VBZ the_DT enhanced_JJ rate_NN of_IN cell_NN division_NN
          in_IN tumor_NN cells_NNS and_CC the_DT requirement_NN for_IN greater_JJR levels_NNS of_IN
          protein_NN synthesis_NN ._. In_IN agreement_NN with_IN this_DT possibility_NN ,_,
          transcripts_NNS encoding_VBG RPs_NNP L_NNP 6_CD and_CC S_NNP 7_CD are_VBP reported_VBN to_TO be_VB
          up-regulated_JJ in_IN regenerating_VBG liver_NN [_NN 33_CD ]_NN ._. However_RB ,_, for_IN
          the_DT study_NN involving_VBG responses_NNS of_IN neuroblastoma_NN cells_NNS to_TO
          N-M_NNP yc_NN ,_, despite_IN the_DT massive_JJ up-regulation_JJ of_IN RP_NNP
          transcripts_NNS ,_, there_EX was_VBD no_DT over-all_JJ increase_NN in_IN the_DT rate_NN
          of_IN protein_NN synthesis_NN [_NN 18_CD ]_NN ._.
          Before_IN considering_VBG potential_JJ functional_JJ consequences_NNS
          of_IN the_DT changes_NNS in_IN RP_NNP expression_NN described_VBD here_RB as_RB well_RB as_IN
          elsewhere_RB ,_, it_PRP must_MD be_VB conceded_VBN that_IN changes_NNS in_IN transcript_NN
          abundance_NN may_MD not_RB necessarily_RB lead_VB to_TO changes_NNS in_IN protein_NN
          expression_NN ._. The_DT present_JJ lack_NN of_IN available_JJ
          antibodies_NNS /_NN antiserum_NN to_TO most_RBS mammalian_JJ RPs_NNP hampers_VBZ such_JJ a_DT
          determination_NN ._. However_RB ,_, even_RB if_IN cases_NNS occur_VBP in_IN which_WDT
          altered_VBD RP_NNP transcript_NN expression_NN does_VBZ not_RB lead_VB to_TO changes_NNS
          in_IN expression_NN of_IN the_DT corresponding_JJ protein_NN ,_, our_PRP$ and_CC
          others_NNS '_POS findings_NNS regarding_VBG selective_JJ regulation_NN of_IN RP_NNP
          transcripts_NNS would_MD then_RB raise_VB the_DT interesting_JJ issue_NN as_IN to_TO
          why_WRB ,_, and_CC the_DT mechanism_NN by_IN which_WDT ,_, transcript_NN and_CC protein_NN
          expression_NN are_VBP uncoupled_JJ ._.
          If_IN at_IN least_JJS some_DT of_IN the_DT NGF-promoted_NNP alterations_NNS in_IN RP_NNP
          transcript_NN abundance_NN lead_NN to_TO changes_NNS in_IN expression_NN of_IN the_DT
          corresponding_JJ proteins_NNS ,_, what_WP might_MD be_VB the_DT functional_JJ
          consequences_NNS ?_. In_IN the_DT present_JJ system_NN ,_, NGF_NNP converts_VBZ
          proliferating_VBG PC_NN 12_CD cells_NNS to_TO a_DT non-proliferating_JJ
          neuronally_RB differentiated_JJ state_NN ._. Our_PRP$ findings_NNS reveal_VBP that_IN
          the_DT relative_JJ overall_JJ abundance_NN of_IN transcripts_NNS for_IN RP_NNP
          proteins_NNS fell_VBN by_IN 1_CD /_NN 3_CD in_IN response_NN to_TO NGF_NNP ._. In_IN addition_NN ,_,
          nearly_RB half_NN of_IN the_DT individual_JJ RP_NNP transcripts_NNS detected_VBD
          showed_VBN significant_JJ changes_NNS in_IN expression_NN and_CC
          approximately_RB 2_CD /_NN 3_CD of_IN these_DT were_VBD decreases_NNS ._. This_DT overall_JJ
          decrease_NN in_IN NGF-promoted_NNP RP_NNP transcript_NN expression_NN and_CC the_DT
          preponderance_NN of_IN decreases_NNS in_IN expression_NN of_IN specific_JJ RP_NNP
          transcripts_NNS compared_VBN to_TO increases_NNS would_MD favor_VB the_DT
          interpretation_NN that_IN the_DT changes_NNS observed_VBD here_RB reflect_VB ,_, at_IN
          least_JJS in_IN part_NN ,_, the_DT transition_NN to_TO the_DT non-dividing_JJ
          phenotype_NN ._. On_IN the_DT other_JJ hand_NN ,_, we_PRP observed_VBD that_IN many_JJ of_IN
          the_DT RP_NNP transcripts_NNS did_VBD not_RB show_VB significant_JJ responses_NNS to_TO
          NGF_NNP and_CC that_IN a_DT number_NN showed_VBD increases_NNS in_IN expression_NN ._.
          This_DT suggests_VBZ that_IN the_DT situation_NN is_VBZ likely_JJ to_TO be_VB more_RBR
          complex_JJ with_IN individual_JJ RPs_NNP perhaps_RB playing_VBG specific_JJ
          roles_NNS not_RB simply_RB associated_VBN with_IN the_DT state_NN of_IN cell_NN
          proliferative_JJ capacity_NN ._. In_IN agreement_NN with_IN this_DT ,_, we_PRP found_VBD
          no_DT significant_JJ change_NN in_IN expression_NN of_IN RP_NNP S_NNP 29_CD transcripts_NNS
          even_RB though_IN these_DT have_VBP been_VBN reported_VBN to_TO be_VB present_JJ at_IN low_JJ
          levels_NNS in_IN growth_NN phase_NN cells_NNS and_CC elevated_VBD in_IN quiescent_JJ
          cells_NNS [_NN 34_CD ]_NN ._.
          In_IN addition_NN to_TO leaving_VBG the_DT cell_NN cycle_NN ,_, NGF-treated_NNP
          PC_NNP 12_CD cells_NNS undergo_VBP neuronal_NN differentiation_NN ._. This_DT raises_VBZ
          the_DT possibility_NN that_IN some_DT of_IN the_DT observed_VBN changes_NNS ,_, as_IN for_IN
          many_JJ other_JJ NGF_NNP regulated_VBN genes_NNS ,_, is_VBZ related_VBN to_TO acquisition_NN
          of_IN the_DT neuronal_NN phenotype_NN ._. An_DT analysis_NN of_IN gene_NN regulation_NN
          in_IN human_JJ NTERA_NNP 2_CD cells_NNS induced_VBN to_TO leave_VB the_DT cell_NN cycle_NN and_CC
          neuronally_RB differentiate_VB in_IN response_NN to_TO retinoic_JJ acid_NN
          revealed_VBD decreases_NNS in_IN RP_NNP transcripts_NNS including_VBG L_NNP 3_CD ,_, L_NNP 7_CD ,_,
          L_NNP 8_CD ,_, L_NNP 10_CD ,_, L_NNP 13_CD ,_, L_NNP 39_CD ,_, S_NNP 2_CD ,_, S_NNP 6_CD ,_, S_NNP 13_CD ,_, S_NNP 16_CD ,_, S_NNP 20_CD ,_, S_NNP 19_CD ,_, S_NNP 23_CD ,_, S_NNP 27_CD A_DT
          and_CC P_NN 0_CD [_NN 35_CD ]_NN ._. Of_IN these_DT ,_, In_IN the_DT present_JJ study_NN only_RB RP_NNP
          transcripts_NNS L_NNP 8_CD and_CC S_NNP 6_CD ,_, S_NNP 16_CD ,_, S_NNP 19_CD showed_VBD significant_JJ down_RB
          regulation_NN in_IN response_NN to_TO NGF_NNP whereas_IN the_DT others_NNS found_VBD in_IN
          the_DT NTERA_NNP 2_CD study_NN either_CC did_VBD not_RB show_VB changes_NNS that_WDT were_VBD
          significant_JJ at_IN the_DT 
          P_NN ≤_NN ._. 01_CD level_NN or_CC underwent_VBD a_DT
          significant_JJ increase_NN (_( RP_NNP S_NNP 27_CD A_DT )_) ._. Curcic_NNP et_CC al_NN ._. [_NN 36_CD ]_NN
          reported_VBD that_DT differentiation_NN of_IN BC_NNP 3_CD H_NNP 1_CD myocytes_NNS is_VBZ
          accompanied_VBN by_IN a_DT drop_NN in_IN L_NNP 32_CD gene_NN transcription_NN ;_: in_IN
          contrast_NN ,_, we_PRP found_VBD no_DT significant_JJ change_NN in_IN transcripts_NNS
          encoding_VBG this_DT RP_NNP ._. In_IN another_DT study_NN ,_, RPs_NNP L_NNP 35_CD a_DT and_NN S_NNP 5_CD were_VBD
          down_RB regulated_VBN during_IN murine_NN erythryolukemia_NN cell_NN
          differentiation_NN [_NN 37_CD ]_NN ;_: we_PRP also_RB observed_VBD decreases_NNS in_IN
          these_DT transcripts_NNS ._. Mutation_NNP of_IN RP_NNP S_NNP 19_CD is_VBZ associated_VBN with_IN
          Blackfan_NNP 's_POS anemia_NN and_CC therefore_RB appears_VBZ to_TO play_VB a_DT
          selective_JJ role_NN in_IN differentiation_NN /_NN proliferation_NN of_IN
          erythropoetic_JJ cells_NNS [_NN 39_CD ]_NN ._. Here_RB ,_, NGF_NNP resulted_VBD in_IN a_DT
          nearly_RB 5_CD -_: fold_VB drop_NN in_IN S_NNP 19_CD transcripts_NNS ._. Thus_RB ,_, although_IN
          changes_NNS in_IN expression_NN of_IN specific_JJ RP_NNP genes_NNS may_MD be_VB
          associated_VBN with_IN differentiation_NN ,_, the_DT pattern_NN of_IN such_JJ
          changes_NNS may_MD reflect_VB the_DT particular_JJ cell_NN type_NN and_CC
          differentiation_NN stimulus_NN that_WDT is_VBZ involved_VBN ._.
          Another_DT condition_NN associated_VBN with_IN changes_NNS in_IN RP_NNP
          expression_NN is_VBZ apoptotic_JJ death_NN ._. RP_NNP L_NNP 4_CD /_NN L_NNP 1_CD transcripts_NNS ,_,
          which_WDT were_VBD not_RB significantly_RB affected_VBN by_IN NGF_NNP ,_, are_VBP
          selectively_RB upregulated_JJ in_IN PC_NN 12_CD cells_NNS prior_RB to_TO 5_CD aza_NN
          cytosine-induced_JJ death_NN and_CC over-expression_JJ of_IN this_DT gene_NN
          in_IN COS-_NNP 7_CD cells_NNS induces_VBZ apoptosis_NNS [_NN 39_CD ]_NN ._. Over-expression_NNP
          of_IN L_NNP 7_CD ,_, L_NNP 13_CD A_DT ,_, S_NNP 29_CD have_VBP been_VBN also_RB reported_VBN to_TO induce_VB
          apoptosis_NNS [_NN 40_CD 41_CD ]_NN ._. In_IN the_DT present_JJ study_NN ,_, NGF_NNP promoted_VBD
          little_JJ if_IN any_DT change_NN in_IN expression_NN of_IN these_DT RP_NNP
          transcripts_NNS ._. Thus_RB ,_, although_IN NGF_NNP is_VBZ an_DT effective_JJ
          anti-apoptotic_JJ factor_NN ,_, these_DT actions_NNS do_VBP not_RB appear_VB to_TO be_VB
          mediated_JJ by_IN down-regulation_JJ of_IN potentially_RB death-inducing_JJ
          RPs_NNP ._.
          At_IN present_JJ ,_, in_IN contrast_NN to_TO studies_NNS on_IN bacterial_JJ and_CC
          archael_NN ribosomes_NNS ,_, relatively_RB little_JJ is_VBZ known_VBN about_IN the_DT
          functions_NNS of_IN individual_JJ mammalian_JJ ribosomal_JJ proteins_NNS (_( [_NN
          42_CD ]_NN ._. However_RB ,_, assuming_VBG that_IN changes_NNS in_IN message_NN
          abundance_NN lead_NN to_TO alterations_NNS in_IN protein_NN levels_NNS ,_, it_PRP is_VBZ
          reasonable_JJ to_TO anticipate_VB that_IN the_DT NGF-promoted_NNP effects_NNS
          observed_VBD here_RB may_MD affect_VB the_DT protein_NN synthetic_JJ capacity_NN
          of_IN the_DT cell_NN in_IN some_DT manner_NN ._. Such_JJ changes_NNS are_VBP unlikely_JJ to_TO
          be_VB global_JJ ;_: NGF_NNP does_VBZ affect_VB the_DT cellular_JJ rate_NN of_IN protein_NN
          synthesis_NN ,_, but_CC this_DT seems_VBZ to_TO be_VB due_JJ at_IN least_JJS in_IN part_NN to_TO
          post-translational_JJ modification_NN of_IN the_DT translational_NN
          machinery_NN [_NN 43_CD ]_NN ._. The_DT alternative_NN is_VBZ that_IN the_DT changes_NNS
          reported_VBD here_RB may_MD result_VB in_IN selective_JJ effects_NNS on_IN
          translation_NN of_IN specific_JJ messages_NNS ._.
          A_DT final_JJ ,_, and_CC important_JJ possibility_NN to_TO consider_VB is_VBZ that_IN
          a_DT number_NN of_IN RPs_NNP appear_VBP to_TO possess_VB extraribosomal_NN
          functions_NNS [_NN 44_CD ]_NN and_CC consequently_RB that_IN the_DT changes_NNS
          reported_VBD here_RB may_MD lead_VB to_TO responses_NNS that_WDT do_VBP not_RB directly_RB
          relate_VB to_TO ribosomal_JJ function_NN ._. For_IN example_NN ,_, RP_NNP L_NNP 18_CD ,_, which_WDT
          was_VBD significantly_RB down-regulated_JJ by_IN NGF_NNP ,_, has_VBZ been_VBN
          reported_VBN to_TO negatively_RB regulate_VB double-stranded_JJ RNA_NNP
          (_( dsRNA_NN )_) -_: activated_VBN protein_NN kinase_NN (_( PKR_NNP )_) [_NN 45_CD ]_NN ._. As_IN an_DT
          additional_JJ example_NN RP_NNP S_NNP 19_CD ,_, which_WDT is_VBZ also_RB down-regulated_JJ
          by_IN NGF_NNP ,_, has_VBZ been_VBN implicated_VBN in_IN erythropoiesis_NNS and_CC has_VBZ
          also_RB been_VBN described_VBN as_IN a_DT monocyte_NN chemotactic_JJ factor_NN [_NN 46_CD
          ]_NN ._. As_IN one_CD last_JJ example_NN ,_, rat_NN RP_NNP L_NNP 9_CD which_WDT we_PRP found_VBD to_TO be_VB
          up-regulated_JJ by_IN NGF_NNP starting_VBG within_IN a_DT few_JJ hours_NNS and_CC
          maximally_RB by_IN 8_CD hrs_NNS ,_, has_VBZ been_VBN shown_VBN to_TO be_VB the_DT ortholog_NN of_IN
          the_DT yeast_NN gene_NN 
          grc_NN 5_CD which_WDT appears_VBZ to_TO be_VB involved_VBN
          in_IN multiple_JJ cellular_JJ functions_NNS including_VBG growth_NN control_NN ,_,
          cytoskeleton_NN control_NN and_CC energy_NN metabolism_NN [_NN 47_CD ]_NN ._.
          Identification_NNP of_IN NGF-regulated_NNP RPs_NNP should_MD now_RB facilitate_VB
          exploration_NN of_IN their_PRP$ potential_JJ roles_NNS in_IN the_DT responses_NNS of_IN
          cells_NNS to_TO neurotrophins_NNS ._.
        
      
      
        Conclusions_NNP
        1_LS ._. SAGE_NNP analysis_NN provides_VBZ a_DT reliable_JJ ,_, quantitative_JJ
        picture_NN of_IN ribosomal_JJ protein_NN expression_NN in_IN PC_NN 12_CD cells_NNS
        before_IN and_CC after_IN long_JJ term_NN exposure_NN to_TO NGF_NNP ._.
        2_LS ._. Transcripts_NNP for_IN ribosomal_JJ proteins_NNS are_VBP among_IN the_DT most_RBS
        abundant_JJ transcripts_NNS in_IN the_DT cells_NNS ;_: however_RB there_EX is_VBZ a_DT wide_JJ
        range_NN between_IN numbers_NNS of_IN transcripts_NNS for_IN individual_JJ RP_NNP
        transcripts_NNS ._.
        3_LS ._. NGF_NNP promotes_VBZ an_DT overall_JJ decrease_NN in_IN relative_JJ RP_NNP
        transcript_NN expression_NN (_( for_IN the_DT 74_CD RP_NNP transcripts_NNS detected_VBD ,_,
        from_IN approximately_RB 5_CD %_NN of_IN total_JJ transcripts_NNS to_TO 3_CD ._. 5_CD %_NN )_) ._. This_DT
        drop_NN represents_VBZ a_DT decrease_NN in_IN relative_JJ expression_NN of_IN
        individual_JJ RP_NNP transcripts_NNS as_RB well_RB as_IN an_DT increase_NN in_IN message_NN
        complexity_NN in_IN NGF-treated_NNP cells_NNS ._.
        4_LS ._. Long_NNP term_NN NGF_NNP treatment_NN of_IN PC_NN 12_CD cells_NNS promotes_VBZ
        statistically_RB significant_JJ changes_NNS in_IN expression_NN of_IN over_IN
        half_NN of_IN the_DT transcripts_NNS encoding_VBG ribosomal_JJ proteins_NNS ._.
        Decreases_NNP in_IN expression_NN outnumbered_VBD increases_NNS by_IN a_DT ratio_NN of_IN
        approximately_RB 2_CD :_: 1_CD ._. The_DT largest_JJS observed_VBN changes_NNS in_IN
        expression_NN are_VBP in_IN the_DT range_NN of_IN 3_CD -_: 5_CD fold_VB ._.
        5_LS ._. For_IN at_IN least_JJS one_CD RP_NNP transcript_NN (_( RPL_NNP 9_CD )_) the_DT response_NN to_TO
        NGF_NNP is_VBZ rapid_JJ ;_: an_DT elevation_NN is_VBZ detected_VBN within_IN 1_CD hr_NN of_IN NGF_NNP
        exposure_NN and_CC reaches_VBZ maximum_NN regulation_NN by_IN 8_CD hrs_NNS ._.
        6_CD ._. Examination_NNP of_IN the_DT literature_NN reveals_VBZ many_JJ other_JJ
        reports_NNS in_IN which_WDT expression_NN of_IN individual_JJ or_CC groups_NNS of_IN RP_NNP
        transcripts_NNS are_VBP regulated_VBN in_IN response_NN to_TO growth_VB factors_NNS ,_,
        differentiation_NN agents_NNS or_CC malignant_JJ transformation_NN ._.
        Comparison_NNP with_IN the_DT present_JJ data_NN indicate_VBP that_IN changes_NNS in_IN
        ribosomal_JJ protein_NN transcripts_NNS is_VBZ regulated_VBN in_IN a_DT cell_NN and_CC
        state_VB dependent_JJ fashion_NN with_IN a_DT large_JJ diversity_NN in_IN the_DT
        particular_JJ RP_NNP transcripts_NNS that_WDT are_VBP subject_JJ to_TO regulation_NN ._.
        Thus_RB ,_, although_IN the_DT ribosome_NN may_MD be_VB regarded_VBN as_RB a_DT "_'' machine_NN "_''
        there_EX is_VBZ a_DT good_JJ deal_NN of_IN potential_JJ for_IN plasticity_NN with_IN
        respect_NN to_TO the_DT expression_NN of_IN its_PRP$ various_JJ components_NNS ._. This_DT
        raises_VBZ the_DT possibilities_NNS that_WDT growth_NN factors_NNS and_CC other_JJ cell_NN
        regulators_NNS may_MD affect_VB ribosomal_JJ function_NN ,_, and_CC thereby_RB the_DT
        capacity_NN of_IN cells_NNS to_TO transcribe_VBP specific_JJ transcripts_NNS ._.
        7_CD ._. In_IN the_DT absence_NN of_IN information_NN about_IN the_DT specific_JJ
        functions_NNS of_IN most_JJS individual_JJ RPs_NNP in_IN mammalian_JJ cells_NNS ,_, one_PRP
        can_MD only_RB speculate_VB at_IN present_JJ on_IN the_DT physiologic_JJ
        significance_NN of_IN the_DT reported_VBN changes_NNS ._. However_RB ,_, it_PRP seems_VBZ
        highly_RB plausible_JJ that_IN the_DT observed_VBN responses_NNS may_MD play_VB roles_NNS
        in_IN NGF-promoted_NNP neuronal_NN differentiation_NN ._. This_DT may_MD be_VB
        mediated_JJ in_IN part_NN by_IN selective_JJ effects_NNS on_IN translation_NN of_IN
        certain_JJ messages_NNS ._. In_IN addition_NN ,_, past_JJ findings_NNS support_VBP the_DT
        possibility_NN that_IN at_IN least_JJS some_DT of_IN the_DT regulated_VBN RPs_NNP have_VBP
        extra-ribosomal_JJ actions_NNS that_WDT may_MD affect_VB neuronal_NN
        differentiation_NN and_CC function_NN ._.
      
      
        Materials_NNS and_CC Methods_NNP
        
          SAGE_NNP and_CC matching_VBG SAGE_NNP tags_NNS with_IN RP_NNP
          transcripts_NNS
          SAGE_NNP libraries_NNS were_VBD prepared_VBN from_IN naïve_NN and_CC 9_CD -_: day_NN
          NGF-treated_NNP PC_NNP 12_CD cells_NNS and_CC sequenced_JJ as_IN previously_RB
          described_VBD [_NN 11_CD ]_NN ._. To_TO match_VB SAGE_NNP tags_NNS with_IN RP_NNP
          transcripts_NNS ,_, tags_NNS were_VBD initially_RB analyzed_VBN with_IN the_DT
          National_NNP Center_NNP for_IN Biotechnology_NNP Information_NNP (_( NCBI_NNP )_) rat_NN
          SAGE_NNP tag_NN to_TO gene_NN mapping_NN database_NN
          ftp_NN :_: /_NN /_NN ncbi_NN ._. nlm_NN ._. nih_NN ._. gov_NN /_NN pub_NN /_NN sage_NN /_NN map_NN /_NN Rn_NNP /_NN Nla_NNP 3_CD ,_, which_WDT
          matches_VBZ possible_JJ 14_CD -_: mer_NN tags_NNS with_IN known_VBN rat_NN genes_NNS and_CC
          expressed_VBD sequence_NN tags_NNS (_( ESTs_NNP )_) ._. With_IN the_DT use_NN of_IN sequences_NNS
          present_JJ in_IN the_DT NCBI_NNP UNIGENE_NNP rat_NN database_NN
          http_NN :_: /_NN /_NN www_NN ._. ncbi_NN ._. nlm_NN ._. nih_NN ._. gov_NN /_NN UniGene_NNP /_NN Rn_NNP ._. Home_NNP ._. htmlpotential_NN
          matches_NNS were_VBD further_RBR scrutinized_VBN to_TO determine_VB whether_IN
          there_EX was_VBD a_DT match_NN at_IN the_DT 15_CD th_NN base_NN and_CC to_TO determine_VB
          whether_IN the_DT matched_VBN sequence_NN was_VBD at_IN the_DT most_JJS 3_CD '_POS end_NN of_IN a_DT
          known_VBN rat_NN transcript_NN or_CC EST_NNP ._. We_PRP considered_VBD only_RB cases_VBZ in_IN
          which_WDT a_DT clear_JJ poly_RB (_( A_DT )_) tail_NN and_CC a_DT polyadenylation_NN signal_NN
          were_VBD present_JJ at_IN the_DT 3_CD '_POS end_NN of_IN the_DT transcript_NN or_CC EST_NNP ._.
          Appropriate_NNP ESTs_NNP were_VBD further_RBR analyzed_VBN by_IN an_DT advanced_VBN
          BLAST_NN search_NN for_IN matches_VBZ with_IN known_VBN rat_NN RP_NNP genes_NNS ._.
          Monte-_NNP Carlo_NNP simulation_NN analysis_NN of_IN the_DT SAGE_NNP data_NN was_VBD
          carried_VBN out_IN using_VBG the_DT SAGE_NNP 300_CD software_NN package_NN [_NN 13_CD ]_NN
          ._.
        
        
          Real_JJ time_NN quantitative_JJ PCR_NNP analysis_NN
          PC_NN 12_CD cells_NNS were_VBD cultured_JJ as_IN previously_RB described_VBD [_NN 12_CD
          ]_NN in_IN complete_JJ medium_NN (_( 85_CD %_NN RPMI_NNP 1640_CD medium_NN ,_, 10_CD %_NN horse_NN
          serum_NN ,_, 5_CD %_NN fetal_JJ bovine_JJ serum_NN )_) ._. Replicate_NNP cultures_NNS were_VBD
          treated_VBN with_IN 50_CD ng_NN /_NN ml_NN rhNGF_NN (_( kindly_RB donated_VBN by_IN Genentech_NNP ,_,
          Inc_NNP ._. )_) for_IN the_DT indicated_VBN times_NNS ._. Total_JJ cellular_JJ RNA_NNP was_VBD
          isolated_VBN as_IN described_VBN previously_RB [_NN 11_CD ]_NN and_CC 1_CD ._. 2_CD -_: 5_CD μg_NN
          was_VBD used_VBN for_IN reverse_NN transcription_NN with_IN 5_CD '_POS -_: T_NN 
          30_CD NN-_NNP 3_CD '_POS primer_NN using_VBG Superscript_NNP II_NNP
          Rnase_NNP H-RT_NNP according_VBG to_TO the_DT manufacturer_NN 's_POS specifications_NNS
          (_( Life_NNP Technologies_NNPS ,_, Grand_NNP Island_NNP ,_, NY_NNP )_) ._. Quantitative_NNP real_JJ
          time_NN PCR_NNP reactions_NNS were_VBD performed_VBN as_IN described_VBN by_IN Troy_NNP et_CC
          al_NN ._. [_NN 48_CD ]_NN ._. GAPDH_NNP was_VBD used_VBN to_TO normalize_VB input_NN cDNA_NN for_IN
          samples_NNS originating_VBG from_IN short-term_JJ NGF_NNP treatments_NNS and_CC
          β-actin_JJ was_VBD used_VBN for_IN this_DT purpose_NN for_IN samples_NNS with_IN
          long-term_JJ NGF_NNP exposure_NN ._.
          Forward_NNP and_CC reverse_VB primers_NNS pairs_NNS used_VBN for_IN
          quantitative_JJ PCR_NNP were_VBD :_: 
          S_NNP 29_CD ,_, 5_CD '_POS GGTATCACAGGGTAGACAGT_NNP 3_CD '_POS and_CC
          5_CD '_POS GGTATCACAGGGTAGACAGT_NNP 3_CD '_POS ;_: 
          L_NNP 9_CD ,_, 5_CD '_POS GAACTCTGAGGAGGGACTTC_NNP 3_CD '_POS and_CC
          5_CD '_POS AAACTGTACTTGTTATCAGGAT_NNP 3_CD '_POS ;_: 
          S_NNP 27_CD -_: 1_CD ,_, 5_CD '_POS CGGCACGAGCGACCTCCCTA_NNP 3_CD '_POS and_CC
          5_CD '_POS GTTCCCACTCATCTTGAATC_NNP 3_CD '_POS ;_: 
          L_NNP 24_CD ,_, 5_CD '_POS CAAGAAAGGACAGTCGGAAA_NNP 3_CD '_POS and_CC
          5_CD '_POS TTCACAGGCTTCACAATCTT_NNP 3_CD '_POS ;_: 
          S_NNP 19_CD ,_, 5_CD '_POS TAACCAGCAGGAGTTCGTCA_NNP 3_CD '_POS and_CC
          5_CD '_POS TTTGTTCTAATGCTTCTTGTT_NNP 3_CD '_POS ;_: β-_NN 
          Actin_NNP ,_, 5_CD '_POS ATCCTGACCCTGAAGTACCC_NNP 3_CD '_POS
          and_CC 5_CD '_POS TACGACCAGAGGCATACAG_NNP 3_CD '_POS ;_: and_CC 
          GAPDH_NNP ,_, 5_CD '_POS GAAACCTGCCAAGTATGATGA_NNP 3_CD '_POS
          and_CC 5_CD '_POS TCTCTCTTGCTCTCAGTATCC_NNP 3_CD '_POS ,_, respectively_RB ._.
        
      
    
  
